Skip to main content
Fig.16 | BMC Neurology

Fig.16

From: Diagnostic biomarkers and immune infiltration profiles common to COVID-19, acute myocardial infarction and acute ischaemic stroke using bioinformatics methods and machine learning

Fig.16

QRT-PCR was performed to validate the expression of S100 A12 in patients with COVID-19, AMI, and AIS. S100 A12 expression was relatively low in healthy individuals, while significant up-regulation was observed in patients. Orange indicates the disease group and blue indicates the normal group, P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us